Explore the words cloud of the GONDOLA AMPS project. It provides you a very rough idea of what is the project "GONDOLA AMPS" about.
The following table provides information about the project.
GONDOLA MEDICAL TECHNOLOGIES SA
|Coordinator Country||Switzerland [CH]|
|Total cost||3˙562˙743 €|
|EC max contribution||2˙493˙920 € (70%)|
1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
|Duration (year-month-day)||from 2020-01-01 to 2021-12-31|
Take a look of project's partnership.
|1||GONDOLA MEDICAL TECHNOLOGIES SA||CH (EPALINGES)||coordinator||2˙493˙920.00|
Neurological conditions such as Parkinson’s and cerebral stroke cause motor disabilities, resulting in walking and balance impairment. These disorders severely affect patient’s independence and quality of life. State-of-the-art treatments and medications have little or no effect. Gondola AMPS is a game-changing proprietary medical device by Gondola Medical Technologies that delivers Automated Mechanical Peripheral Stimulation (AMPS). After treatment, most patients experience a drastic improvement of their motor symptoms. This non-invasive treatment takes less than two minutes and two applications a week are sufficient for a long-lasting effect. Gondola AMPS has already been adopted by 450 patients in several countries; boosted self-confidence and quality of life are consistently reported. The treatment can be delivered at home via a personalised device or at medical settings with a multi-patient device.
In the EU only, more than 7 million Parkinson patients and stroke survivors are affected by long-term disabilities and this will continue to grow at a rapid pace. Mobility losses and related care, equipment and infrastructure, bear huge costs estimated to represent an annual €50 billion. Gondola AMPS contributes to addressing this major economic and societal challenge. The invention is patent-protected in several countries. Ten clinical trials and as many peer-reviewed scientific publications conclude to the effectiveness of Gondola AMPS at strongly improving motor symptoms. Gondola AMPS brings a non-invasive and cost-effective answer to a widespread unmet medical need. Break-even is planned in less than three years while making Gondola Medical Technologies a global leader. To support this strong growth more than 150 highly qualified jobs will be created across Europe and eventually in USA, Canada and Japan.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GONDOLA AMPS" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "GONDOLA AMPS" are provided by the European Opendata Portal: CORDIS opendata.